BTIG analyst Lance Jessurun reaffirmed a Neutral rating on PayPal (NASDAQ:PYPL) stock, expressing caution ahead of the ...

BTIG analyst Carl Reichardt Jr. maintained a Neutral rating on shares of NVR Inc . (NYSE:NVR), while slightly lowering ...

BTIG analyst Vincent Caintic maintained a Buy rating on Atlanticus Holdings (ATLC – Research Report) yesterday and set a price target of ...

BTIG analyst Vincent Caintic maintained a Buy rating on Affirm Holdings (AFRM – Research Report) yesterday and set a price target of $81.00.

--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual ...

BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $622 from $561 and keeps a Buy rating on the shares after ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

What damage might Monday's ongoing selloff do to the technical set-up for stocks? Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already sug ...

iCAD, Inc. announced its participation in the upcoming BTIG at Snowbird: 12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 11-12, 2025, in Utah ...

BTIG Research began coverage on shares of Arcturus Therapeutics (NASDAQ:ARCT – Get Free Report) in a research report issued on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual MedTech, Digital Health, Life Science ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, toda ...